Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
A Randomized, Double-Blind, Placebo-controlled, Parallel Design Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
Sponsor: Vedic Lifesciences Pvt. Ltd.
Listed as NCT05212259, this NA trial focuses on Joint Pain and remains ongoing. Sponsored by Vedic Lifesciences Pvt. Ltd., it has been updated 9 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Jan 2026 — Present [monthly]
Unknown NA
-
Sep 2025 — Jan 2026 [monthly]
Unknown NA
-
Dec 2024 — Sep 2025 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Dec 2022 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Dec 2022 [monthly]
Not Yet Recruiting NA
-
Apr 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
Feb 2022 — Apr 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Vedic Lifesciences Pvt. Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .